-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721.O2.6 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities II

Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, Antibody Therapy, Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, AML, MDS, clinical trials, Translational Research, Clinical Research, Chronic Myeloid Malignancies, Diseases, patient-reported outcomes, Therapies, Immunotherapy, Lymphoid Malignancies, registries, Myeloid Malignancies, Transplantation
Monday, December 12, 2022: 2:45 PM-4:15 PM
393-396 (Ernest N. Morial Convention Center)
Moderators:
Sawa Ito, MD, University of Pittsburgh and Meng Lv, MD, PhD, Peking University People's Hospital
Disclosures:
No relevant conflicts of interest to declare.
2:45 PM

Jesus Duque Afonso, MD1*, Jürgen Finke, MD, PhD2,3, Maud Ngoya4*, Jacques-Emmanuel Galimard, PhD5*, Charles Craddock6, Kavita Raj7*, Adrian Bloor, PhD FRCP FRCPath8*, Emma Nicholson, MD, PhD9*, Matthias Eder, MD10*, Kim H. Orchard, MBBS, PhD11, Thomas Valerius, MD12, John A. Snowden, MBBS PhD13*, Eleni Tholouli, MD, MRCPath14*, Charles Crawley15, Matthew P. Collin, MD, PhD16, Keith Wilson, FRCPath, MRCP, MBBS17*, Alain Gadisseur, MD, PhD18*, Rachel Elizabeth Protheroe, FRCPath, PhD, MBBS, FRCP19*, Eva Maria Wagner, MD20, Bipin Savani, MD21, Alexandros Spyridonidis22*, Fabio Ciceri, MD23*, Arnon Nagler, MD24 and Mohamad Mohty, MD PhD25

1Department of Hematology/Oncology/Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
2Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
3Department of Medicine, Hematology-Oncology, University of Freiburg, Freiburg, Germany
4EBMT Lymphoma Working Party Paris Office, Paris, France
5EBMT ALWP, Paris, France
6Department of Haematology, University Hospital Birmingham NHS Trust, Queen Elizabeth Medical Centre, Birmingham, ENG, United Kingdom
7University College London Hospitals NHS Trust, London, United Kingdom
8Haematology, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
9Department of Hematology, The Royal Marsden Hospital, University College London, London, GBR
10Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
11Wessex Blood and Marrow Transplant and Cell Therapy Program, Southampton Univ. Hospitals, Southampton, ENG, United Kingdom
12Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany, Kiel, Germany;, Kiel, Germany
13Sheffield University Teaching Hospitals, Sheffield, United Kingdom
14Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom
15Department of Haematology, Addenbrookes University Hospital, Cambridge, United Kingdom
16Adult HSCT unit, Newcastle, United Kingdom, Newcastle, United Kingdom
17University Hospital of Wales, Cardiff, United Kingdom
18Department of Haematology, Antwerp University Hospital, Edegem, Belgium
19Bristol Royal Hospital for Children Department of Paediatric Oncology/BMT, Bristol, United Kingdom
20University Hospital Mainz, Universitären Centrums für Tumorerkrankungen, Mainz, Germany
21Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
22Hematology Stem Cell Transplant Unit, School of Medicine, University of Patras, PATRA, Greece
23Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
24Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel
25EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR 938, Sorbonne University, Paris, France

3:00 PM

Larisa Shelikhova*, Rimma Khismatullina*, Dmitriy Balashov*, Alexey Kazachenok*, Yakov Muzalevsky*, Julia Abugova*, Julia Skvortsova*, Alexander Popov*, Dmitry Pershin*, Daria Kobyzeva*, Alexey Nechesnyuk*, Yulia Olshanskaya*, Svetlana Kozlovskaya*, Sergey Blagov*, Natalia Miakova*, Galina Novichkova*, Alexey Maschan, MD* and Michael Maschan*

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

3:15 PM

Maxime Jullien, MD1*, Thierry Guillaume, MD, PhD1*, Amandine Le Bourgeois, MD1*, Pierre Peterlin, MD2*, Alice Garnier, MD1*, Marion Eveillard, PharmD, PhD3*, Marie C Béné, PharmSciD, PhD3* and Patrice Chevallier, MD1

1Hematology Department, Nantes University Hospital, Nantes, France
2Nantes University Hospital, Nantes, France
3Biology Department, Nantes University Hospital, Nantes, France

3:30 PM

Peter Westervelt, MD PhD1*, Partow Kebriaei, MD2, Mark Juckett, MD3, Andrew S. Artz, MD, MS4, Onyee Chan, MD5, Philip L. McCarthy, MD6, Sherif S Farag, MD, PhD7, Anurag K. Singh, MD8, Eytan Stein, MD9, Jeffrey Humphrey, MD10, William Baeder, MPH11*, Ji Hyun Lee, MD, MPH10*, Alison Occhiuti, MS10*, Jeanie Tang, BS10*, David Santos, BS10*, Kirk Bertelsen, PhD10*, Balaji Mahender, BPharm, MS10*, Nicole Henry, BSN, RN10* and Shawn Rose, MD, PhD10

1Washington University, St. Louis, MO
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
3Masonic Cancer Center, University of Minnesota, Minneapolis, MN
4City of Hope, Duarte, CA
5Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
6Roswell Park Comprehensive Cancer Center, Buffalo, NY
7IU Simon Cancer Center, Indianapolis, IN
8Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
9Memorial Sloan Kettering Cancer Center, New York, NY
10Magenta Therapeutics, Cambridge, MA
11Magenta Therapeutics, Burlington, NJ

3:45 PM

Richard E Champlin, MD1, Esther Bachar Lustig, PhD1*, Qaiser Bashir, MD1, Betul Oran, MD, MSc1*, Steven M. Kornblau, MD2, Chitra Hosing, MD1, Amin M Alousi, MD1, Uday R Popat, MD1, Jessica M McCarty1*, Peter F Thall, PhD3*, Bouthaina S. Dabaja, MD4*, Wei-Hsin Liu, MD1*, Giang Dang1*, Karla Castro1*, Alejandro Ramirez1*, Michael Spiotto1*, Susan Wu, MD4*, Penny Fang, MD4*, Indreshpal Kaur, PhD1*, Katy Rezvani, MD1, Elizabeth J Shpall, MD1 and Yair Reisner, PhD1,5

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
5CPRIT Scholar in Cancer Research., The University of Texas MD Anderson Cancer Center, Houston, TX

4:00 PM

Yu Akahoshi, MD, PhD1,2*, Yuma Tada3*, Emiko Sakaida, MD, PhD4, Machiko Kusuda, MD5*, Noriko Doki6*, Naoyuki Uchida, MD, PhD7, Takahiro Fukuda8*, Masatsugu Tanaka9*, Masashi Sawa, MD, PhD10*, Yuta Katayama, MD, PhD11, Ken-ichi Matsuoka, MD, PhD12, Yukiyasu Ozawa13*, Makoto Onizuka, MD, PhD14, Junya Kanda, MD, PhD15, Yoshinobu Kanda, MD, PhD5,16, Yoshiko Atsuta17,18* and Hideki Nakasone, MD, PhD5

1Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
2The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
3Osaka International Cancer Institute, Osaka, JPN
4Division of Hematology, Department of Hematology, Chiba University Hospital, Chiba City, Japan
5Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama City, Japan
6Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
7Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan
8Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
9Department of Hematology, Kanagawa Cancer Center, Yokohama, KAN, Japan
10Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan
11Department of Hematology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan
12Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
13Japanese Red Cross Nagoya First Hospital, Nagoya, JPN
14Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
15Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
16Division of Hematology, Jichi Medical University, Shimotsuke, Japan
17Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
18Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan

*signifies non-member of ASH